Portfoliotracker

DBV Technologies S.A.

DBV.PA · PARIS · Healthcare Biotechnology 19/100 E

1,859 €
▼ −0,013 (−0,70 %)
Trading delayed by 15 min
Price as of 17. 11. 13:49, fetched 17. 11. 14:05
Next earnings–
Ex-dividend–
Analysts–
50 / 200 day average– / –

Price

Portfoliotracker score19 / 100 Market cap588 mil. € P/E– Forward P/E-12,6 P/S157,4 P/B4,4 EV/EBITDA-2,2 Dividend yield– FCF yield– EPS-0,52 € Net margin0,0 % Return on equity-205,9 % Beta-0,21 Debt / equity0,05
52-week range 1,53 to 4,50
3-month average volume1,2 M

We do not have financial statements yet

The company reports in USD, while the price is quoted in EUR. We do not convert statements between currencies yet, because the multiples (P/E, P/S and others) would come out wrong, so we do not show them here. You can see the price and its history above.

Fundamentals

Loading key figures…

Insiders, analysts and people

All trades and changes

Loading insiders, analysts and opinions…

Co se právě děje

AI souhrn
Objednat AI souhrn, co se u firmy právě děje Vytvoří se jednou na pozadí a pak ho uvidí všichni. Ve verzi Free 3 objednávky měsíčně.

About the company

DBV Technologies S.A., a clinical-stage biopharmaceutical company, engages in the research and development of epicutaneous immunotherapy products in France. Its product pipeline comprising Viaskin Peanut, an immunotherapy product, which has completed Phase 3 clinical trial for the treatment of peanut allergies; and Viaskin Milk which is in Phase 1/2 clinical trial for the treatment of immunoglobulin E (IgE) mediated or cow's milk protein allergy and eosinophilic esophagitis. The company's earlier stage research programs include celiac disease. In addition, the company develops Viaskin technology platform, a platform to potentially treat food allergy. It has a collaboration with Nestlé Health Science to develop MAG1C, a ready-to-use atopy patch test for the diagnosis of non-IgE mediated CMPA in infants and toddlers. DBV Technologies S.A. was incorporated in 2002 and is headquartered in Châtillon, France.

Employees
179
Country
France
Data since
29. 3. 2012

Explore further

Similar companies GNFT.PAIPH.PAALCLS.PANANO.PAADOC.PA

Intraday chart

Your own portfolio, properties and finances in one place.

The account is free with no time limit. Only you see your data; nobody adds it up with others.

This is saved to your account. You can keep browsing, calculating and comparing without signing in.

Welcome back

Sign in and pick up where you left off.

or continue with

No account yet? Create a free account